Rationale for individualizing haemophilia care

Benny Sørensen, Günter Auerswald, Gary Benson, Ivo Elezović, Markus Felder, Thierry Lambert, Massimo Morfini, Eduardo Remor, Peter Salaj, Elena Santagostino, Silva Z. Šalek, Rolf Ljung

Research output: Contribution to journalArticlepeer-review

Abstract

Owing to the heterogeneity in the clinical phenotype of haemophilia A and B, it is now recognized that disease severity (based on factor VIII/IX activity) may no longer be the most appropriate guide for treatment and that a 'one-size-fits-all' approach is unlikely to achieve optimal therapy. Based on the present literature and consensus views of a group of experts in the field, this article highlights key gaps in the understanding of the diverse relationships between bleeding phenotype and factors such as joint health, genetic susceptibility, laboratory parameters, quality of life and management of pain. Early prophylaxis is a potential 'gold standard' therapy and issues surrounding inhibitor development, variations in its clinical use and long-term outcomes are discussed. Comprehensive treatment should be individualized for all patients (including those with mild or moderate haemophilia and carriers). Wherever possible all patients should be given prophylaxis. However, adult patients with a milder haemophilia phenotype may be candidates for ceasing prophylaxis and switching to on-demand treatment. Regardless, all treatment (on-demand and prophylaxis) should be tailored towards both the patient's personal needs and their clinical profile. In addition, as the associations between risk factors (psychosocial, condition-related and treatment-related) and clinical features are unique to each patient, an individualized approach is required to enable patients to alter their behaviour in response to them. The practical methodologies needed to reach this goal of individualized haemophilia care, and the health economic implications of this strategy, are ongoing topics for discussion.

Original languageEnglish
Pages (from-to)849-857
Number of pages9
JournalBlood Coagulation and Fibrinolysis
Volume26
Issue number8
DOIs
Publication statusPublished - 2015

Keywords

  • Haemophilia
  • Health economics
  • Individualized care
  • Inhibitors
  • On-demand
  • Prophylaxis

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Rationale for individualizing haemophilia care'. Together they form a unique fingerprint.

Cite this